ArticlePloS one2025
Laboratory risk assessment of Beauveria bassiana AAD16 on two species of ladybird beetle.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Beauveria bassiana AAD16, isolated from Allomyrina dichotoma, shows promise as a mycoinsecticide against various coleopterans. However, assessing non-target impacts on beneficial beetles like ladybirds is crucial before commercialization. Here we assessed the compatibility between ladybird beetles and B. bassiana AAD16. The virulence of the AAD16 strain was compared with that of an available commercial strain, B. bassiana GHA, for two developmental stages (adults and 3rd instar larvae) of two coccinellids, Harmonia axyridis Pallas and Chilocorus spp. Say using the topical (1μl) application method. The ST50 for the two life stages of the two ladybird beetles were not different between the two tested fungal strains. Mycosis rates recorded from the dead bodies were also not significant except in the 3rd instar which showed 36 and 63% from AAD16 and GHA strains in H. axyridis, while those of Chilocorus spp. were 40 and 63%, respectively. In adult stage, the mycosis rates of H. axyridis (males and females tested separately) were (20-23) % and (26-30) % from the AAD16 and GHA strains, while those of Chilocorus spp. (unsexed) were 23 and 30%, respectively. AAD16 caused similar rates of mortality in the adult stages of both species. Therefore, we conclude that B. bassiana AAD16 would not increase risk to these beneficial insects compared to a similar pathogen commercialized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.